Mettler-Toledo International Inc (MTD)
NYSE · Healthcare · Diagnostics & Research
Mettler-Toledo International Inc is a Healthcare company with a market capitalization of $25.54B and a trailing P/E ratio of 29.7.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 7, 2026 | $8.33 | $8.35 | -0.2% |
| Q4 2025 | February 5, 2026 | $13.36 | $12.81 | +4.3% |
| Q3 2025 | November 6, 2025 | $10.57 | $10.23 | +3.3% |
| Q2 2025 | July 31, 2025 | $10.09 | $9.60 | +5.1% |
| Q1 2025 | May 1, 2025 | $8.19 | $7.88 | +3.9% |
| Q4 2024 | February 6, 2025 | $12.41 | $11.72 | +5.9% |
Other Diagnostics & Research Stocks
Frequently Asked Questions
What is Mettler-Toledo International Inc's market cap?
As of June 29, 2026, Mettler-Toledo International Inc (MTD) has a market capitalization of $25.54B.
What is Mettler-Toledo International Inc's P/E ratio?
Mettler-Toledo International Inc trades at a trailing price-to-earnings (P/E) ratio of 29.7. Its forward P/E is 27.0.
Does Mettler-Toledo International Inc pay a dividend?
Mettler-Toledo International Inc does not currently pay a dividend.
What sector is MTD in?
Mettler-Toledo International Inc is in the Healthcare sector, specifically the Diagnostics & Research industry.
What was Mettler-Toledo International Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), Mettler-Toledo International Inc reported revenue of $4.03B and net income of $869.19M.
Ask your own questions about MTD
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.